| P2093 | author name string | Young Min Park | |
| | Jaemin Lee | |
| | Hyung Woo Kim | |
| | Sun Hong Yoo | |
| | Yong Sun Choi | |
| | Sang Jong Park | |
| | Won Sohn | |
| | Jin Young Heo | |
| | Jung Ho Won | |
| P2860 | cites work | Hepatitis B virus infection and fatty liver in the general population | Q44930660 |
| | Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. | Q46573520 |
| | Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients | Q46665419 |
| | Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. | Q50561038 |
| | Hepatic steatosis has no impact on the outcome of treatment in patients with chronic hepatitis B infection. | Q64936845 |
| | Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease | Q72082159 |
| | The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation | Q81350918 |
| | Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes | Q81440458 |
| | Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B | Q82192886 |
| | The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses | Q84114728 |
| | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| | Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 |
| | Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 |
| | Understanding interobserver agreement: the kappa statistic | Q29615540 |
| | Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 |
| | EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 |
| | Management of hepatocellular carcinoma | Q29616230 |
| | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 |
| | Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up | Q31132229 |
| | Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients | Q33734225 |
| | NAFLD, NASH and liver cancer | Q34374372 |
| | Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 |
| | AASLD guidelines for treatment of chronic hepatitis B. | Q34501660 |
| | Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma | Q34544988 |
| | Lamivudine for patients with chronic hepatitis B and advanced liver disease | Q34551713 |
| | Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort | Q35136036 |
| | KASL Clinical Practice Guidelines: Management of chronic hepatitis B. | Q36153966 |
| | Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma | Q36953790 |
| | Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence | Q37696527 |
| | Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. | Q37886042 |
| | Impact of the obesity epidemic on cancer | Q38271295 |
| | Excess risk of primary liver cancer in patients with diabetes mellitus | Q38506217 |
| | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study. | Q42150413 |
| | Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease | Q42232487 |
| | Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine. | Q42234528 |
| | Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. | Q42984773 |
| | Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection | Q44323346 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| | entecavir | Q418586 |
| | hepatocellular carcinoma | Q1148337 |
| | chronic hepatitis | Q62019625 |
| P304 | page(s) | 339-349 | |
| P577 | publication date | 2016-09-25 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B. | |
| P478 | volume | 22 | |